Your browser doesn't support javascript.
loading
Harm-to-Benefit of Three Decades of Prostate Cancer Screening in Black Men.
Basourakos, Spyridon P; Gulati, Roman; Vince, Randy A; Spratt, Daniel E; Lewicki, Patrick J; Hill, Alexander; Nyame, Yaw A; Cullen, Jennifer; Markt, Sarah C; Barbieri, Christopher E; Hu, Jim C; Trapl, Erika; Shoag, Jonathan E.
Afiliación
  • Basourakos SP; Department of Urology, New York-Presbyterian Hospital, Weill Cornell Medical Center, New York.
  • Gulati R; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle.
  • Vince RA; Department of Urology, University of Michigan, Ann Arbor.
  • Spratt DE; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Cleveland.
  • Lewicki PJ; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland.
  • Hill A; Department of Urology, New York-Presbyterian Hospital, Weill Cornell Medical Center, New York.
  • Nyame YA; Department of Urology, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland.
  • Cullen J; Department of Urology, University of Washington, Seattle.
  • Markt SC; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland.
  • Barbieri CE; Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland.
  • Hu JC; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland.
  • Trapl E; Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland.
  • Shoag JE; Department of Urology, New York-Presbyterian Hospital, Weill Cornell Medical Center, New York.
NEJM Evid ; 1(6)2022 Jun.
Article en En | MEDLINE | ID: mdl-35721307

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Idioma: En Revista: NEJM Evid Año: 2022 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Idioma: En Revista: NEJM Evid Año: 2022 Tipo del documento: Article